Next Article in Journal
Single-Cell Transcriptomics for Unlocking Personalized Cancer Immunotherapy: Toward Targeting the Origin of Tumor Development Immunogenicity
Next Article in Special Issue
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
Previous Article in Journal
Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1
Previous Article in Special Issue
Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Bienfait et al. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers 2023, 15, 349

1
Anaesthesiology and Pain Department, Institut de Cancérologie de l’Ouest, 49100 Angers, France
2
Biometrics Department, Institut de Cancérologie de l’Ouest, 49100 Angers, France
3
Pain Management Consultation Center, Centre Hospitalier Départemental Vendée, 85925 La Roche-sur-Yon, France
*
Author to whom correspondence should be addressed.
Cancers 2023, 15(14), 3613; https://doi.org/10.3390/cancers15143613
Submission received: 25 June 2023 / Accepted: 25 June 2023 / Published: 14 July 2023
(This article belongs to the Special Issue Side Effects of Anticancer Therapy: Prevention and Management)
In the original publication [1], there was a mistake in the published Figure 6. The labels of the two lines in Figure 6 should be reversed. “Three or more applications” should be above “Two applications or fewer”. The corrected Figure 6 appears below.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Bienfait, F.; Julienne, A.; Jubier-Hamon, S.; Seegers, V.; Delorme, T.; Jaoul, V.; Pluchon, Y.-M.; Lebrec, N.; Dupoiron, D. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers 2023, 15, 349. [Google Scholar] [CrossRef] [PubMed]
Figure 6. HCCP efficacy for patients who received three or more applications compared to those who received fewer. * means that there is a statistically significant difference.
Figure 6. HCCP efficacy for patients who received three or more applications compared to those who received fewer. * means that there is a statistically significant difference.
Cancers 15 03613 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bienfait, F.; Julienne, A.; Jubier-Hamon, S.; Seegers, V.; Delorme, T.; Jaoul, V.; Pluchon, Y.-M.; Lebrec, N.; Dupoiron, D. Correction: Bienfait et al. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers 2023, 15, 349. Cancers 2023, 15, 3613. https://doi.org/10.3390/cancers15143613

AMA Style

Bienfait F, Julienne A, Jubier-Hamon S, Seegers V, Delorme T, Jaoul V, Pluchon Y-M, Lebrec N, Dupoiron D. Correction: Bienfait et al. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers 2023, 15, 349. Cancers. 2023; 15(14):3613. https://doi.org/10.3390/cancers15143613

Chicago/Turabian Style

Bienfait, Florent, Arthur Julienne, Sabrina Jubier-Hamon, Valerie Seegers, Thierry Delorme, Virginie Jaoul, Yves-Marie Pluchon, Nathalie Lebrec, and Denis Dupoiron. 2023. "Correction: Bienfait et al. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers 2023, 15, 349" Cancers 15, no. 14: 3613. https://doi.org/10.3390/cancers15143613

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop